Clinical Trials Sponsored by Tianjin Tasly Pharmaceutical Co., Ltd

Total 3954 results

Guizhou Bailing Group Pharmaceutical Co Ltd
China-Japan Friendship Hospital

Completed

Clinical Trials for the Optimal Dosage of Tang Ning Tongluo Capsule (TNTL)

Accidental Exposure While Preparing Drug for Administration

China
Hyuk moon Kim
Dong-A Pharmaceutical Co., Ltd.

Unknown

Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy

Neutropenia

Korea, Republic of
Nang Kuang Pharmaceutical Co., Ltd.
Buddhist Tzu Chi General Hospital

Completed

A Clinical Study for Assessment of the Efficacy and Safety of Mirtazapine (Smilon) in Depression Patients With Pain

Depression | Pain

Taiwan
Beijing Jishuitan Hospital
Chinese PLA General Hospital; Tianjin Hospital; Beijing Tinavi Medical Technology...

Completed

Clinical Trial for the Application of Tirobot System

Robotic Surgical Procedures | Fusion of Spine (Disease)

China
China Medical University Hospital
China Medical University, China; Qualitix Clinical Research Co., Ltd.; Tian-I...

Not yet recruiting

Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease

COVID-19 | Influenza Viral Infections

Taiwan
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease

Dry Eye Disease

China
ASLAN Pharmaceuticals
Syneos Health; bioRASI, LLC; CMIC Co, Ltd. Japan

Completed

Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer (TreeTopp)

Biliary Tract Cancer

United States, Australia, China, Hong Kong, Hungary, Japan, Korea, Republic of, Poland, Singapore, Spain, Taiwan
First Affiliated Hospital of Zhejiang University
Ascletis Pharmaceuticals Co., Ltd.

Completed

Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects (RTV)

Healthy Volunteer

China
Cancer Institute and Hospital, Chinese Academy...
Jiangsu Hansoh Pharmaceutical Co., Ltd.; GeneCast Biotechnology Co., Ltd.

Enrolling by invitation

Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection (APEX)

Non-small Cell Lung Carcinoma

China
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease

Dry Eye Disease

China
Beijing Pins Medical Co., Ltd
Peking University First Hospital; Beijing Tiantan Hospital

Recruiting

Rechargeable Implantable Vagus Nerve Stimulation System for Drug-Refractory Epilepsy

Drug-Refractory Epilepsy

China
Cure&Sure Biotech Co., LTD
Beijing Tiantan Hospital; Shenzhen Second People's Hospital

Recruiting

A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96

Glioma of Brain

China
First Affiliated Hospital of Zhejiang University
Ascletis Pharmaceuticals Co., Ltd.

Terminated

Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection

2019-nCoV

China
GeneScience Pharmaceuticals Co., Ltd.
Huazhong University of Science and Technology

Completed

Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children (Phase 1)

Growth Hormone Deficiency
Kohei Shitara
Ono Pharmaceutical Co. Ltd; Bayer Yakuhin, Ltd.

Completed

Regorafenib and Nivolumab Simultaneous Combination Therapy (REGONIVO)

Advanced and Metastatic Solid Tumor

Japan
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Shanghai Public Health Clinical Center; Beijing Simoonrecord Pharmaceutical...

Completed

A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

Tuberculosis

China
Yunpeng Liu
CSPC Ouyi Pharmaceutical Co., Ltd.

Not yet recruiting

Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma

Biliary Tract Carcinoma

China
Xi'An Aolitai Pharmaceutical Technology Co Ltd

Recruiting

A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects

Drug-Induced Liver Injury | Cholestatic Liver Injury | Mixed Liver Injury

China
Jae Myung Park
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Efficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients (NSAID)

Osteoarthritis
Jung Im Jung
Taejoon Pharmaceutical Co., Ltd.

Recruiting

Chest CT Using Low-concentration Iodine Contrast Media

Pulmonary Disease

Korea, Republic of
Asan Medical Center
Korean Cancer Study Group; Boryung Pharmaceutical Co., Ltd

Recruiting

A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer (BRISK)

Advanced Solid Tumors | Metastatic Cancer | Solid Tumors

Korea, Republic of
Peking Union Medical College Hospital
CSPC Ouyi Pharmaceutical Group Co., Ltd.

Not yet recruiting

Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis

Cryptococcal Meningitis

China
The Affiliated Hospital of Qingdao University
Changzhou Pharmaceutical Factory Co., Ltd

Not yet recruiting

Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects

Pharmacokinetics | Safety
Second Affiliated Hospital of Nanchang University
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

Almonertinib With Bevacizumab for EGFR-Mutant NSCLC Patients With Leptomeningeal Metastasis (ATTRACT)

NSCLC | EGFR Activating Mutation | Leptomeningeal Metastasis

China
Huazhong University of Science and Technology
CSPC Ouyi Pharmaceutical Co., Ltd.

Recruiting

Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma

Gastric Cancer

China
The Affiliated Hospital of Qingdao University
Wenzhou Haihe Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Eldecalcitol Soft Capsule in Healthy Chinese Subjects

Healthy

China
Huazhong University of Science and Technology
CSPC Ouyi Pharmaceutical Co., Ltd.

Unknown

A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

Biliary Tract Cancer

China
First Affiliated Hospital of Zhejiang University
Shenyang Sunshine Pharmaceutical Co., LTD.

Unknown

A Pharmacokinetics and Safety Study of Narfurine Hydrochloride Orally Disintegrating Tablets

Improvement of Pruritus in Hemodialysis Patients

China
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Completed

Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

China
Seung-Jung Park
CardioVascular Research Foundation, Korea; Boryung Pharmaceutical Co., Ltd

Terminated

Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)

Coronary Artery Disease

Korea, Republic of
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Completed

A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Chulalongkorn University
The Kidney Foundation of Thailand; Siam Pharmaceutical Co Ltd

Completed

Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis

Peritoneal Dialysis Associated Peritonitis

Thailand
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Unknown

A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Jong Woo Chung
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

A Study on the Effect of Cilostazol in Patients With Chronic Tinnitus (CITI-ESR)

Tinnitus

Korea, Republic of
Jiangsu Simcere Pharmaceutical Co., Ltd.
The First People's Hospital of Lianyungang

Unknown

Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients

Esophageal Cancer

China
Japan Clinical Oncology Group
Taiho Pharmaceutical Co., Ltd.; Ministry of Health, Labour and Welfare, Japan; Yakult Honsha Co., LTD

Completed

A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer

Gastric Cancer

Japan
Sang Hyun Ihm, MD PhD
Daiichi Sankyo Korea Co., Ltd.; Daewoong Pharmaceutical Co. LTD.

Completed

Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM (EARTH)

Hypertension

Korea, Republic of
Pfizer
Parexel; SACT INTERNATIONAL Co., LTD.; Acronet; Bellsystem24 , Inc.; Mitsubishi Kagaku... and other collaborators

Completed

Dalacin-T Gel Post Approval Study

Acne Vulgaris
The First Hospital of Jilin University
CSPC Ouyi Pharmaceutical Co., Ltd.

Not yet recruiting

The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.

Diffuse Large B-cell Lymphoma

China
Nanfang Hospital of Southern Medical University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients (PANORAMA)

Chemotherapy | Immunotherapy

China
Peking University People's Hospital
Beijing Qingyi Taike Pharmaceutical Technology Co., Ltd

Not yet recruiting

LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Relapsed/Refractory Acute Myeloid Leukemia
Qu Yiqing
Qilu Pharmaceutical Co., Ltd.

Recruiting

Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Pulmonary Disease, Chronic Obstructive

China
Guangzhou Sinogen Pharmaceutical Co., Ltd
Parexel; ClinChoice Enterprise Management (Shanghai) Limited

Recruiting

Study of SGN1 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

United States, China
The Central Hospital of Lishui City
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging

Nephrogenic Fibrosing Dermopathy

China
Southern California University of Health Sciences
Sun Ten Pharmaceutical Co Ltd.

Completed

Effects of Lagenbone on Bone Mineral Density

Osteoporosis

United States
University of California, San Francisco
Taiho Pharmaceutical Co., Ltd.; Sirtex Medical

Completed

Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases

Rectal Cancer | Colon Cancer | Liver Metastases

United States
Zhejiang Hisun Pharmaceutical Co. Ltd.
Opera CRO, a TIGERMED Group Company

Unknown

A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19

COVID-19

China, Germany, Romania
First Affiliated Hospital of Zhejiang University
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Unknown

A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults（Part 2）

Safety Issues | Effect of Drugs

China
Sichuan Kelun Pharmaceutical Research Institute...
307 Hospital of PLA

Unknown

Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
isRed Pharma & Biotech Research Corporation
Yung Shin Pharmaceutical Ind. Co., Ltd.

Unknown

A Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of a Reference Drug Product

Healthy Adult Subjects

Taiwan

Clinical Trials Sponsored by Tianjin Tasly Pharmaceutical Co., Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations